Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
批准号:
8767371
负责人:
E. Albert Reece
金额:
$42.92万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2018-05-31
关键词:
AcetylationAgeAmericanAntioxidantsApoptosisBindingBinding ProteinsCaringCell membraneCellsCellular StressChildCongenital AbnormalityCpG IslandsDNADNA MethyltransferaseDNA Modification MethylasesDNMT3aDeacetylaseDiabetes MellitusDown-RegulationEndoplasmic ReticulumEnzymesEventExhibitsExposure toGenetic TranscriptionHealthHyperglycemiaHypermethylationKnock-outKnockout MiceMediatingMethylationMitochondriaMolecularMutationNeural Tube DefectsNeural tubeNeuroepithelial CellsOxidative StressPathway interactionsPhosphorylationPhosphorylation SitePost-Translational Protein ProcessingPregnancy in DiabeticsProtein IsoformsProtein Kinase CProteinsRelative (related person)Risk FactorsRoleSignal PathwayStructural Congenital AnomaliesTestingTimeTransgenic MiceWomanWorkbasediabeticdiabetic embryopathyendoplasmic reticulum stressglycemic controlknowledge basemalformationmaternal diabetesmitochondrial dysfunctionmutantmyristoylated alanine-rich C kinase substratenon-diabeticnoveloverexpressionpreventpromoterpublic health relevancereproductiverestorationsuccesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Congenital malformations occur in up to 10% of babies born to diabetic women. Optimal glycemic control is difficult to achieve and maintain, and even transient exposure to hyperglycemia can cause malformations. This current proposal is formulated on the basis of our findings relative to the PKC pathway, which is critically involved i the induction of diabetic embryopathy. Because the molecular intermediates downstream PKC activation have not been determined, we have advanced a novel hypothesis that maternal hyperglycemia-induced PKCa/d activation reduces the expression of SIRT2 through DNA hypermethylation. SIRT2 downregulation prevents sustainable antioxidant enzyme expression and induces MARCKS hyperacetylation, which contributes to MARCKS phosphorylation. PKC-dependent SIRT2 downregulation and MARCKS phosphorylation in the developing neural tube are responsible for cellular stresses that cause neuroepithelial cell apoptosis and NTD formation. Aim 1 will determine whether PKCa and PKCd suppress SIRT2 expression through DNA hypermethylation in diabetic embryopathy. We hypothesize that that PKCa and PKCd increases the expression of de novo DNA methyltransferases (DNMT3A/B), which induce hypermethylation in the SIRT2 promoter and inhibit its expression. Aim 2 will determine the role of SIRT2 in PKC-induced cellular stress, MARCKS phosphorylation and NTD formation in diabetic embryopathy. Our working hypothesis is that downregulation of SIRT2 decreases antioxidant enzyme expression, which results in oxidative and endoplasmic reticulum stress, and leads to an increase in MARCKS acetylation and phosphorylation, which contributes to cellular stress. Aim 3 will determine the causal role of MARCKS phosphorylation in diabetes-induced cellular stress, apoptosis and NTD formation. We will test the hypothesis that PKCa/d-dependent MARCKS phosphorylation induces cellular stress and mitochondrial dysfunction, resulting in apoptosis and NTD formation. The success of this project will significantly fill the gaps in the current knowledge base regarding events that cause diabetic embryopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10267759
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10453652
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10676158
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
-
批准号:10116005
-
项目类别:
-
资助金额:$58.69万
-
财政年份:2020
-
负责人:E. Albert Reece
-
依托单位:
The 15th Biennial Meeting of the Diabetes in Pregnancy Study Group North America
-
批准号:9398326
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2017
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:8856232
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10653120
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10189679
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10016378
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
-
批准号:10440363
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2014
-
负责人:E. Albert Reece
-
依托单位:
Construction Grant 8th Floor BRB
-
批准号:7839132
-
项目类别:
-
资助金额:$500.0万
-
财政年份:2010
-
负责人:E. Albert Reece
-
依托单位:
UMB Technology Resource Center
-
批准号:7935928
-
项目类别:
-
资助金额:$732.91万
-
财政年份:2010
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:8004693
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2009
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:8118807
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2008
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:7897889
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2008
-
负责人:E. Albert Reece
-
依托单位:
Mechanisms of Diabetic Embryopathy and Molecular Pathways
-
批准号:7689344
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2008
-
负责人:E. Albert Reece
-
依托单位:
General Clinical Research Center
-
批准号:7571693
-
项目类别:
-
资助金额:$236.88万
-
财政年份:2002
-
负责人:E. Albert Reece
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:7031759
-
项目类别:
-
资助金额:$248.93万
-
财政年份:2002
-
负责人:E. Albert Reece
-
依托单位:
General Clinical Research Center
-
批准号:7174523
-
项目类别:
-
资助金额:$241.71万
-
财政年份:2002
-
负责人:E. Albert Reece
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6622728
-
项目类别:
-
资助金额:$98.01万
-
财政年份:1999
-
负责人:E. Albert Reece
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: